Format
Sort by

Send to

Choose Destination

Search results

Items: 10

1.

Limited contribution of common genetic variants to risk for liver injury due to a variety of drugs.

Urban TJ, Shen Y, Stolz A, Chalasani N, Fontana RJ, Rochon J, Ge D, Shianna KV, Daly AK, Lucena MI, Nelson MR, Molokhia M, Aithal GP, Floratos A, Pe'er I, Serrano J, Bonkovsky H, Davern TJ, Lee WM, Navarro VJ, Talwalkar JA, Goldstein DB, Watkins PB; Drug-Induced Liver Injury Network.; DILIGEN.; EUDRAGENE.; Spanish DILI Registry.; International Serious Adverse Events Consortium..

Pharmacogenet Genomics. 2012 Nov;22(11):784-95. doi: 10.1097/FPC.0b013e3283589a76.

2.

[Hepatotoxicity, a global problem with local features: toward the creation of a Pan-American Hepatotoxicity Network].

Lucena MI, Cohen H, Hernández N, Bessone F, Dacoll C, Stephens C, Borraz Y, Ulzurrun E, Bruguera M, Andrade RJ.

Gastroenterol Hepatol. 2011 May;34(5):361-8. doi: 10.1016/j.gastrohep.2011.01.003. Spanish.

PMID:
21419525
3.

Mitochondrial superoxide dismutase and glutathione peroxidase in idiosyncratic drug-induced liver injury.

Lucena MI, García-Martín E, Andrade RJ, Martínez C, Stephens C, Ruiz JD, Ulzurrun E, Fernandez MC, Romero-Gomez M, Castiella A, Planas R, Durán JA, De Dios AM, Guarner C, Soriano G, Borraz Y, Agundez JA.

Hepatology. 2010 Jul;52(1):303-12. doi: 10.1002/hep.23668.

PMID:
20578157
4.

Phenotypic characterization of idiosyncratic drug-induced liver injury: the influence of age and sex.

Lucena MI, Andrade RJ, Kaplowitz N, García-Cortes M, Fernández MC, Romero-Gomez M, Bruguera M, Hallal H, Robles-Diaz M, Rodriguez-González JF, Navarro JM, Salmeron J, Martinez-Odriozola P, Pérez-Alvarez R, Borraz Y, Hidalgo R; Spanish Group for the Study of Drug-Induced Liver Disease..

Hepatology. 2009 Jun;49(6):2001-9. doi: 10.1002/hep.22895.

PMID:
19475693
5.

[Liver injury induced by "natural remedies": an analysis of cases submitted to the Spanish Liver Toxicity Registry].

García-Cortés M, Borraz Y, Lucena MI, Peláez G, Salmerón J, Diago M, Martínez-Sierra MC, Navarro JM, Planas R, Soria MJ, Bruguera M, Andrade RJ.

Rev Esp Enferm Dig. 2008 Nov;100(11):688-95. Spanish.

6.

Glutathione S-transferase m1 and t1 null genotypes increase susceptibility to idiosyncratic drug-induced liver injury.

Lucena MI, Andrade RJ, Martínez C, Ulzurrun E, García-Martín E, Borraz Y, Fernández MC, Romero-Gomez M, Castiella A, Planas R, Costa J, Anzola S, Agúndez JA; Spanish Group for the Study of Drug-Induced Liver Disease..

Hepatology. 2008 Aug;48(2):588-96. doi: 10.1002/hep.22370. Erratum in: Hepatology. 2009 Mar;49(3):1058.

PMID:
18666253
7.

[An analysis of the causes, characteristics, and consequences of reexposure to a drug or compound responsible for a hepatotoxicity event].

Fernández-Castañer A, García-Cortés M, Lucena MI, Borraz Y, Peláez G, Costa J, Anzola S, Salmerón J, Avila S, Durán JA, Malcón de Dios A, Romero-Gómez M, Madrazo A, Muñoz-Yagüe T, Andrade RJ.

Rev Esp Enferm Dig. 2008 May;100(5):278-84. Spanish. Erratum in: Rev Esp Enferm Dig. 2008 Nov;100(11):740.

8.

Analysis of IL-10, IL-4 and TNF-alpha polymorphisms in drug-induced liver injury (DILI) and its outcome.

Pachkoria K, Lucena MI, Crespo E, Ruiz-Cabello F, Lopez-Ortega S, Fernandez MA, Romero-Gomez M, Madrazo A, Durán JA, de Dios AM, Borraz Y, Navarro JM, Andrade RJ; Spanish Group for the Study of Drug-Induced Liver Disease (Grupo de Estudio para las Hepatopatías Asociadas a Medicamentos (GEHAM))..

J Hepatol. 2008 Jul;49(1):107-14. doi: 10.1016/j.jhep.2008.03.017. Erratum in: J Hepatol. 2009 Mar;50(3):636.

PMID:
18485518
9.

Evaluation of naranjo adverse drug reactions probability scale in causality assessment of drug-induced liver injury.

García-Cortés M, Lucena MI, Pachkoria K, Borraz Y, Hidalgo R, Andrade RJ; Spanish Group for the Study of Drug-induced Liver Disease (grupo de Estudio para las Hepatopatías Asociadas a Medicamentos, Geham)..

Aliment Pharmacol Ther. 2008 May;27(9):780-9. doi: 10.1111/j.1365-2036.2008.03655.x.

10.

Outcome of acute idiosyncratic drug-induced liver injury: Long-term follow-up in a hepatotoxicity registry.

Andrade RJ, Lucena MI, Kaplowitz N, García-Muņoz B, Borraz Y, Pachkoria K, García-Cortés M, Fernández MC, Pelaez G, Rodrigo L, Durán JA, Costa J, Planas R, Barriocanal A, Guarner C, Romero-Gomez M, Muņoz-Yagüe T, Salmerón J, Hidalgo R.

Hepatology. 2006 Dec;44(6):1581-8.

PMID:
17133470
Items per page

Supplemental Content

Loading ...
Support Center